Dr. Reddy's Laboratories
Hyderabad, India
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Dr. Reddy's Laboratories
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Hyderabad, India
- Modalities
- Small Molecule API, Generics, Biosimilars, Biologics (Drug Substance & Drug Product), Oligonucleotides, Steroids / Corticosteroids, Oncology / HPAPI, Sterile Injectables / Fill-Finish, Peptide API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Dr. Reddy's Laboratories
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Generics, Biosimilars, Biologics (Drug Substance & Drug Product), Oligonucleotides, Steroids / Corticosteroids, Oncology / HPAPI, Sterile Injectables / Fill-Finish, Peptide API
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (9 modalities)
Recent News 10 articles
Dr. Reddy's Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply - Medical Dialogues
OneSource's partner Dr. Reddy's receives Health Canada approval for Semaglutide Injection - Business Standard
Dr. Reddy's Semaglutide Injection Wins Health Canada Approval with OneSource as CDMO Partner - IndiaMedToday
OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide - Indian Pharma Post
Edity, Aurigene to Collaborate on Cell Therapy Discovery Services for Clinical Development - BioPharm International
We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene - Indian Pharma Post
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma - BioSpace
Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103M - Endpoints News
Anshul Agrawal Joins SCL Lifesciences Ltd as CBO – Knowledge Centre and Head CDMO - hrtoday.in
OneSource reports net loss of ₹47 cr in Q3 FY26; revenue falls 26% - ET Pharma
Frequently Asked Questions About Dr. Reddy's Laboratories
What is Dr. Reddy's Laboratories's CDMO Signal Score?
Dr. Reddy's Laboratories has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Dr. Reddy's Laboratories for a manufacturing program?
Use the free AI matchmaker to compare Dr. Reddy's Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Anthem Biosciences
Bengaluru, India
Small Molecule API, Biologics, Peptide API, Oligonucleotide, ADC, Fermentation (Microbial), HPAPI, Biosimilars, Drug Discovery / Medicinal Chemistry
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Laurus Labs
Hyderabad, India
Small Molecule API, Finished Dosage Form (FDF), CDMO (small molecule), Biologics / Large Molecule, Microbial Fermentation, Peptide API, Cell & Gene Therapy (early-stage investment), Anti-retroviral API, Oncology API, ADC (emerging)
Fresenius Kabi
Bad Homburg, Germany
Biologics (Sterile Injectables), Monoclonal Antibody, Biosimilars, Small Molecule API, HPAPI / Oncology Injectables, mRNA, Cell Therapy (equipment/processing platform), Sterile Fill-Finish, Compounding (outsourcing facility)
Axplora
Raubling, Germany
Small Molecule API, HPAPI / High-Potency API, Steroids / Corticosteroids, ADC Payload / Linker, Oligonucleotide / Peptide (purification), Preparative Chromatography, Flow Chemistry, Hazardous Chemistry, Lyophilization